挑逗出差异化病态与良性肺炎肠道炎的因素
Julia Song1, Biqi Zhang, David Mahvi
1From the Harvard Medical School (J.S., B.Z., D.M., T.D., R.A.); Center for Surgery and Public Heath, Brigham and Women's Hospital (J.S., M.S., M.C.-A., T.D., R.A.); Department of Surgery (J.S., B.Z., D.M., M.S., M.C.-A., T.D., R.A.), Brigham and Women's Hospital, Boston, Massachusetts; Department of Surgery (M.S.), Yale New Haven Hospital, New Haven, Connecticut; and Memorial Sloan Kettering Cancer Center (D.M.), New York City, New York.
肺炎肠道 (PI) 可能是严重的. 使用门静脉气体,多段PI,血管压缩剂使用,腹膜炎,白细胞瘤和末端器官损伤的新型诺莫грам有助于预测严重病例并指导手术决策.
科学领域:
- 胃肠病学 胃肠病学
- 外科胃肠道外科手术
- 放射学 放射学是一门学科.
背景情况:
- 肠道肺炎 (PI) 是一种罕见的放射性发现,管理指南不清楚.
- 鉴于证据有限,区分良性PI和严重PI是具有挑战性的.
- 严重PI的预测因素需要识别以指导临床决策.
研究的目的:
- 确定病理性 (严重) 肺炎肠道病的关键预测因素.
- 开发一个工具来预测严重PI的可能性.
- 帮助PI患者进行手术决策.
主要方法:
- 在334名成年患者的回顾性队列研究中,有PI的放射性证据.
- 排除具有舒适护理或并发性血管封闭过程的患者.
- 病理性PI的定义是缺血性/穿孔性肠道或手术前死亡.
主要成果:
- 27%的患者接受了探索性腹腔切除术;其中65%的人患有缺血性/穿孔肠道.
- 病理性PI在69名患者中被确定 (拉巴切除术或手术前死亡).
- 确定了关键预测因素:门静脉气体,多段PI,血管压缩剂使用,腹膜炎,白细胞病变和末端器官损伤.
结论:
- 纳米图包含已识别的预测因素,可以估计病理性PI的概率.
- 这种名图可以帮助临床医生做出明智的外科决定.
- 对于临床应用,需要进一步验证名录.
相关概念视频
Pneumonia II: Pathophysiology
Histology of the Small Intestine
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Renewal of Intestinal Stem Cells


